Patents Assigned to SPIKIMM
  • Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof
    Patent number: 12281155
    Abstract: The invention relates to antibodies against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2), in particular human neutralizing monoclonal antibodies against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) having a broad neutralization spectrum, and their use for the diagnosis, monitoring, prevention, and treatment of SARS-CoV-2 infection and associated disease (COVID-19).
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: April 22, 2025
    Assignees: INSTITUT PASTEUR, SPIKIMM
    Inventors: Antoine Pau, Hugo Mouquet, Cyril Planchais